AU6517398A - Therapeutic agent for autoimmune diseases - Google Patents
Therapeutic agent for autoimmune diseasesInfo
- Publication number
- AU6517398A AU6517398A AU65173/98A AU6517398A AU6517398A AU 6517398 A AU6517398 A AU 6517398A AU 65173/98 A AU65173/98 A AU 65173/98A AU 6517398 A AU6517398 A AU 6517398A AU 6517398 A AU6517398 A AU 6517398A
- Authority
- AU
- Australia
- Prior art keywords
- therapeutic agent
- autoimmune diseases
- autoimmune
- diseases
- therapeutic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP9-74858 | 1997-03-27 | ||
| JP7485897 | 1997-03-27 | ||
| PCT/JP1998/001318 WO1998043638A1 (fr) | 1997-03-27 | 1998-03-25 | Agent therapeutique pour maladies auto-immunes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU6517398A true AU6517398A (en) | 1998-10-22 |
Family
ID=13559449
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU65173/98A Abandoned AU6517398A (en) | 1997-03-27 | 1998-03-25 | Therapeutic agent for autoimmune diseases |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU6517398A (ja) |
| WO (1) | WO1998043638A1 (ja) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6323206B1 (en) | 1996-07-12 | 2001-11-27 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6509346B2 (en) | 1998-01-21 | 2003-01-21 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6613905B1 (en) | 1998-01-21 | 2003-09-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| US6433165B1 (en) | 1998-01-21 | 2002-08-13 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| BR9910144A (pt) | 1998-01-21 | 2002-04-02 | Millennium Pharm Inc | Antagonistas de receptores de quimiocinas e seu uso |
| US7271176B2 (en) | 1998-09-04 | 2007-09-18 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use thereof |
| US7541365B2 (en) | 2001-11-21 | 2009-06-02 | Millennium Pharmaceuticals, Inc. | Chemokine receptor antagonists and methods of use therefor |
| TWI291467B (en) | 2002-11-13 | 2007-12-21 | Millennium Pharm Inc | CCR1 antagonists and methods of use therefor |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH30676A (en) * | 1986-07-22 | 1997-09-16 | Boehringer Ingelhein Kg | Hetrazepine compounds which have useful pharmaceutical utility |
| US4851423A (en) * | 1986-12-10 | 1989-07-25 | Schering Corporation | Pharmaceutically active compounds |
| WO1989010363A1 (en) * | 1988-04-28 | 1989-11-02 | Schering Corporation | Fused polycyclic compounds, compositions, methods of manufacture and their use as paf antagonists, antihistamines and/or antiinflammatory agents |
| IL91386A0 (en) * | 1988-08-24 | 1990-04-29 | Boehringer Ingelheim Kg | Method for treating autoimmune diseases by using a paf antagonist and pharmaceutical compositions comprising it |
| KR920003928B1 (ko) * | 1988-09-20 | 1992-05-18 | 히사미쯔세이야꾸 가부시기가이샤 | 신규의 디벤즈[b,e]옥세핀유도체 |
| JP2899028B2 (ja) * | 1989-12-01 | 1999-06-02 | 協和醗酵工業株式会社 | ジベンゾオキセピン誘導体 |
| JPH0940662A (ja) * | 1995-05-24 | 1997-02-10 | Kyowa Hakko Kogyo Co Ltd | 三環式化合物 |
-
1998
- 1998-03-25 WO PCT/JP1998/001318 patent/WO1998043638A1/ja active Application Filing
- 1998-03-25 AU AU65173/98A patent/AU6517398A/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998043638A1 (fr) | 1998-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU7378198A (en) | Therapeutic ultrasound system | |
| AU6513298A (en) | Therapeutic compositions | |
| AUPO203996A0 (en) | Therapeutic uses | |
| AUPO665397A0 (en) | Novel therapy for constipation | |
| GB2323531B (en) | Therapeutic formulations | |
| AU5387898A (en) | Pharmaceutical agents | |
| AU2789397A (en) | Diagnostic drugs for autoimmune diseases | |
| AU1673297A (en) | Therapeutic agent for diabetes | |
| AU8266798A (en) | Cd154 blockade therapy for autoimmune diseases | |
| AU6436998A (en) | Therapeutic uses for antioxidants | |
| AU2976597A (en) | Autoimmune disease therapeutic agent | |
| AU5315096A (en) | 19-oxygenated steroids as therapeutic agents | |
| AU6517398A (en) | Therapeutic agent for autoimmune diseases | |
| AU7449698A (en) | Therapeutic agents for respiratory diseases | |
| AU1171099A (en) | Therapeutic agents | |
| GB9700555D0 (en) | Therapeutic agents | |
| EP0878200A4 (en) | THERAPEUTIC AGENT FOR OPHTHALMIC DISEASES | |
| AU697487B2 (en) | Therapeutic agent for ischemic diseases | |
| AU7641098A (en) | Therapeutic composition | |
| AU4459797A (en) | Peptide as diagnostic and therapeutic agent for autoimmune diseases | |
| GB9510223D0 (en) | Therapeutic agent | |
| AU3190595A (en) | Corneal therapeutic agent | |
| AU5330198A (en) | Therapeutic compounds | |
| AUPO314896A0 (en) | Therapeutic agent | |
| AUPP105997A0 (en) | Therapeutic agents |